Ethical Issues and Practical Challenges Raised by Internal Investigations in the Life Sciences Industry

Biden Administration Issues Rules Requiring Insurer Transparency on Drug Spending, Rebates and Fees: What Manufacturers Need to Know

In House Warrior with Daniel Kracov